Nair N. Epidemiology and pathogenesis of heart failure with preserved ejection fraction. Rev Cardiovasc Med. 2020;21(4):531–40.

Article  PubMed  Google Scholar 

Savarese G, Vedin O, D'Amario D, et al. Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure. JACC Heart Fail. 2019;7(4):306–17.

Article  PubMed  Google Scholar 

Cuijpers I, Simmonds SJ, van Bilsen M, et al. Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities. Basic Res Cardiol. 2020;115(4):39.

Article  PubMed  PubMed Central  Google Scholar 

Boengler K, Leybaert L, Ruiz-Meana M, Schulz R. Connexin 43 in mitochondria: what do we really know about its function? Front Physiol. 2022;13:928934.

Article  PubMed  PubMed Central  Google Scholar 

Shin KT, Nie ZW, Zhou W, et al. Connexin 43 knockdown induces mitochondrial dysfunction and affects early developmental competence in porcine embryos. Microsc Microanal. 2020;26(2):287–96.

Article  CAS  PubMed  Google Scholar 

Yi DG, Hong S, Huh WK. Mitochondrial dysfunction reduces yeast replicative lifespan by elevating RAS-dependent ROS production by the ER-localized NADPH oxidase Yno1. PLoS One. 2018;13(6):e0198619.

Article  PubMed  PubMed Central  Google Scholar 

Mishra S, Kass DA. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2021;18(6):400–23.

Article  PubMed  PubMed Central  Google Scholar 

Bode D, Wen Y, Hegemann N, et al. Oxidative stress and inflammatory modulation of Ca(2+) handling in metabolic HFpEF-related left atrial cardiomyopathy. Antioxidants (Basel). 2020;9(9):860.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu J, Xiong Y, Zhang Y, et al. The molecular mechanisms of regulating oxidative stress-induced ferroptosis and therapeutic strategy in tumors. Oxidative Med Cell Longev. 2020;2020:8810785.

Article  Google Scholar 

Kajarabille N, Latunde-Dada GO. Programmed cell-death by ferroptosis: antioxidants as mitigators. Int J Mol Sci. 2019;20(19):4968.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu B, Zhao C, Li H, et al. Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis. Biochem Biophys Res Commun. 2018;497(1):233–40.

Article  CAS  PubMed  Google Scholar 

Wagner S, Schürmann S, Hein S, Schüttler J, Friedrich O. Septic cardiomyopathy in rat LPS-induced endotoxemia: relative contribution of cellular diastolic Ca(2+) removal pathways, myofibrillar biomechanics properties and action of the cardiotonic drug levosimendan. Basic Res Cardiol. 2015;110(5):507.

Article  CAS  PubMed  Google Scholar 

Efentakis P, Varela A, Chavdoula E, et al. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy. Cardiovasc Res. 2020;116(3):576–91.

Article  CAS  PubMed  Google Scholar 

Yu L, Yuan K, Park BM, Kim SH. Modification of levosimendan-induced suppression of atrial natriuretic peptide secretion in hypertrophied rat atria. Eur J Pharmacol. 2018;829:54–62.

Article  CAS  PubMed  Google Scholar 

Rodríguez-González R, Pollesello P, Baluja A, Álvarez J. Effects of Levosimendan on inflammation and oxidative stress pathways in a lipopolysaccharide-stimulated human endothelial cell model. Biol Res Nurs. 2019;21(5):466–72.

Article  PubMed  Google Scholar 

Zhao L, Tian L, Wang S, et al. Levosimendan in rats decreases acute kidney injury after cardiopulmonary resuscitation by improving mitochondrial dysfunction. Transl Androl Urol. 2021;10(7):3010–20.

Article  PubMed  PubMed Central  Google Scholar 

Burkhoff D, Borlaug BA, Shah SJ, et al. Levosimendan improves hemodynamics and exercise tolerance in PH-HFpEF: results of the randomized placebo-controlled HELP trial. JACC Heart Fail. 2021;9(5):360–70.

Article  PubMed  Google Scholar 

Kim S-N, Kwon H-J, Im S-W, et al. Connexin 43 is required for the maintenance of mitochondrial integrity in brown adipose tissue. Sci Rep. 2017;7(1):7159.

Article  PubMed  PubMed Central  Google Scholar 

Akhmedov AT, Rybin V, Marín-García J. Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart. Heart Fail Rev. 2015;20(2):227–49.

Article  CAS  PubMed  Google Scholar 

Dikalova AE, Pandey A, Xiao L, et al. Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circ Res. 2020;126(4):439–52.

Article  CAS  PubMed  Google Scholar 

Ren JX, Li C, Yan XL, et al. Crosstalk between oxidative stress and ferroptosis/oxytosis in ischemic stroke: possible targets and molecular mechanisms. Oxidative Med Cell Longev. 2021;2021:6643382.

Article  Google Scholar 

Schiattarella GG, Altamirano F, Tong D, et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature. 2019;568(7752):351–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lam CSP, Arnott C, Beale AL, et al. Sex differences in heart failure. Eur Heart J. 2019;40(47):3859–68c.

Article  PubMed  Google Scholar 

MacDonald MR, Petrie MC, Varyani F, et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29(11):1377–85.

Article  PubMed  Google Scholar 

Ilieșiu AM, Hodorogea AS. Treatment of heart failure with preserved ejection fraction. Adv Exp Med Biol. 2018;1067:67–87.

Article  PubMed  Google Scholar 

Adam M, Meyer S, Knors H, et al. Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure. Sci Rep. 2015;5:9704.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Obokata M, Kane GC, Reddy YN, et al. Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study. Circulation. 2017;135(9):825–38.

Article  PubMed  Google Scholar 

Homme RP, Zheng Y, Smolenkova I, Singh M, Tyagi SC. Remote hind-limb ischemia mechanism of preserved ejection fraction during heart failure. Front Physiol. 2021;12:745328.

Article  PubMed  PubMed Central  Google Scholar 

Zhao Y, Wang C, Hong X, et al. Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome. Kidney Int. 2019;95(4):815–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edwards DN, Salmeron K, Lukins DE, et al. Integrin α5β1 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke. J Cereb Blood Flow Metab. 2020;40(8):1695–708.

Article  CAS  PubMed  Google Scholar 

Ji M, Cheng J, Zhang D. Oxycodone protects cardiac microvascular endothelial cells against ischemia/reperfusion injury by binding to sigma-1 receptor. Bioengineered. 2022;13(4):9628–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Epifantseva I, Shaw RM. Intracellular trafficking pathways of Cx43 gap